Neurotrophin-regulated signalling pathways, Philos Trans R Soc Lond B Biol Sci, vol.361, p.16939974, 1473. ,
Trk receptor tyrosine kinases: a bridge between cancer and neural development, Cancer Lett, vol.169, issue.2, p.11431098, 2001. ,
TRKing down an old oncogene in a new era of targeted therapy. Cancer discovery, vol.5, p.4293234, 2014. ,
Dependence receptor TrkC is a putative colon cancer tumor suppressor, Proc Natl Acad Sci, vol.110, issue.8, p.3581924, 2013. ,
Targeting neurotrophin-3 and its dependence receptor tyrosine kinase receptor C: a new antitumoral strategy, Expert opinion on therapeutic targets, vol.15, issue.7, p.21473736, 2011. ,
NTRK3 is a potential tumor suppressor gene commonly inactivated by epigenetic mechanisms in colorectal cancer, PLoS Genet, vol.9, issue.7, p.3708790, 2013. ,
, Dependence receptors and colorectal cancer. Gut, vol.63, issue.11, p.25163468, 2014.
Context is everything for dependence receptors in colorectal cancer, Proc Natl Acad Sci U S A, vol.110, issue.8, p.3581887, 2013. ,
The TrkC receptor induces apoptosis when the dependence receptor notion meets the neurotrophin paradigm, Proc Natl Acad Sci, vol.104, issue.33, p.17686986, 2007. ,
Neurotrophin receptors TrkA and TrkC cause neuronal death whereas TrkB does not, Nature, vol.467, issue.7311, pp.59-63, 2010. ,
Dependence Receptors and Cancer: Addiction to Trophic Ligands, Cancer Res, vol.75, issue.24, p.26627011, 2015. ,
Neurotrophin-3 production promotes human neuroblastoma cell survival by inhibiting TrkC ,
URL : https://hal.archives-ouvertes.fr/hal-00475272
, J Clin Invest, vol.120, issue.3, pp.850-858, 2010.
The dependence receptor TrkC triggers mitochondria-dependent apoptosis upon Cobra-1 recruitment, Mol Cell, vol.51, issue.5, p.24034695, 2013. ,
Nuclear targeting signal recognition: a key control point in nuclear transport?, Bioessays, vol.22, issue.6, 2000. ,
Karyopherins and nuclear import. Current opinion in structural biology, vol.11, pp.703-718, 2001. ,
The neogenin intracellular domain regulates gene transcription via nuclear translocation, Mol Cell Biol, vol.28, issue.12, p.18391016, 2008. ,
Presenilin-dependent "gamma-secretase" processing of deleted in colorectal cancer (DCC), J Biol Chem, vol.278, issue.33, p.12840034, 2003. ,
Vertebrate hairy and Enhancer of split related proteins: transcriptional repressors regulating cellular differentiation and embryonic patterning, Oncogene, vol.20, issue.58, p.11840327, 2001. ,
The Notch target genes Hey1 and Hey2 are required for embryonic vascular development, Genes Dev, vol.18, issue.8, p.395849, 2004. ,
Hey1, a mediator of notch signaling, is an androgen receptor corepressor, Mol Cell Biol, vol.25, issue.4, p.548017, 2005. ,
Small-molecule MDM2 antagonists as a new therapy concept for neuroblastoma, Cancer Res, vol.66, issue.19, p.17018622, 2006. ,
Increased frequency of aberrations in the p53/MDM2/p14(ARF) pathway in neuroblastoma cell lines established at relapse, Cancer Res, vol.66, issue.4, p.16489014, 2006. ,
Identification of p53 regulators by genome-wide functional analysis, Proc Natl Acad Sci U S A, vol.101, issue.10, p.373483, 2004. ,
DNMT1 and DNMT3b cooperate to silence genes in human cancer cells, Nature, vol.416, issue.6880, p.11932749, 2002. ,
DOI : 10.1038/416552a
A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy, Science, vol.285, issue.5434, p.10481009, 1999. ,
Target gene analysis by microarrays and chromatin immunoprecipitation identifies HEY proteins as highly redundant bHLH repressors, PLoS Genet, vol.8, issue.5, p.3355086, 2012. ,
DOI : 10.1371/journal.pgen.1002728
URL : https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1002728&type=printable
Mechanisms of epigenetic and cell-type specific regulation of Hey target genes in ES cells and cardiomyocytes, Journal of molecular and cellular cardiology, vol.79, p.25446183, 2015. ,
Hey bHLH transcription factors, Curr Top Dev Biol, vol.110, p.25248480, 2014. ,
DOI : 10.1016/b978-0-12-405943-6.00008-7
Distinct p53 genomic binding patterns in normal and cancer-derived human cells, Cell Cycle, vol.10, issue.24, p.3272258, 2011. ,
DOI : 10.4161/cc.10.24.18383
URL : http://europepmc.org/articles/pmc3272258?pdf=render
Definition of a consensus binding site for p53, Nat Genet, vol.1, issue.1, p.1301998, 1992. ,
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene, Cell, vol.80, issue.2, pp.293-302, 1995. ,
Differential regulation of the proapoptotic multidomain protein Bak by p53 and p73 at the promoter level, Cell Death Differ, vol.18, issue.7, p.21233848, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00608717
, , p.3131957
Potentiation of neuroblastoma metastasis by loss of caspase-8, Nature, vol.439, issue.7072, pp.95-104, 2006. ,
Expression of TrkA, TrkB and TrkC in human neuroblastomas, J Neurooncol, vol.31, issue.1-2, p.9049830, 1997. ,
The MSX1 homeobox transcription factor is a downstream target of PHOX2B and activates the Delta-Notch pathway in neuroblastoma, Exp Cell Res, vol.314, issue.4, p.18201699, 2008. ,
The concordance between RNA-seq and microarray data depends on chemical treatment and transcript abundance, Nat Biotechnol, vol.32, issue.9, p.4243706, 2014. ,
DOI : 10.1038/nbt.3001
URL : http://europepmc.org/articles/pmc4243706?pdf=render
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma, Nature, vol.455, issue.7215, pp.967-70, 2008. ,
Apoptosis-the p53 network, J Cell Sci, vol.116, p.12972501, 2003. ,
DOI : 10.1242/jcs.00739
, Lancet, vol.369, issue.9579, p.17586306, 2007.
Programmed cell death in neuronal development, Science, vol.340, issue.6128, p.23559240, 2013. ,
Regulation of the neural crest cell fate by N-myc: promotion of ventral migration and neuronal differentiation, Development, vol.124, issue.10, p.9169842, 1997. ,
Mechanisms of embryonal tumor initiation: distinct roles for MycN expression and MYCN amplification, Proc Natl Acad Sci U S A, vol.101, issue.34, p.15314226, 2004. ,
, , p.515113
MYCN promotes the expansion of Phox2B-positive neuronal progenitors to drive neuroblastoma development, Am J Pathol, vol.175, issue.2, p.2716980, 2009. ,
Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALKmutated neuroblastoma, Oncotarget, vol.5, issue.9, p.4058037, 2014. ,
Specification and connectivity of neuronal subtypes in the sensory lineage, Nat Rev Neurosci, vol.8, issue.2, pp.114-141, 2007. ,
HeyL regulates the number of TrkC neurons in dorsal root ganglia, Dev Biol, vol.334, issue.1, pp.142-51, 2009. ,
MDM2-p53 interaction in paediatric solid tumours: preclinical rationale, biomarkers and resistance, Current drug targets, vol.15, issue.1, p.24387312, 2014. ,
Mutation of the p53 gene in neuroblastoma and its relationship with N-myc amplification, Cancer Res, vol.53, issue.17, p.8358734, 1993. ,
Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas, Cancer Res, vol.53, issue.21, p.8221663, 1993. ,
Absence of p53 gene mutations in primary neuroblastomas, Cancer Res, vol.53, issue.21, p.8221661, 1993. ,
High Frequency of p53/MDM2/p14ARF Pathway Abnormalities in Relapsed Neuroblastoma, Clin Cancer Res, vol.16, issue.4, p.2842933, 2010. ,
The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor, Genes Dev, vol.24, issue.15, p.2912554, 2010. ,
The isoforms of the p53 protein. Cold Spring Harbor perspectives in biology, vol.2, p.2829963, 2010. ,
Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma, Cell death & disease, vol.4, p.3668636, 2013. ,
Statistics review 12: survival analysis, Critical care, vol.8, issue.5, p.1065034, 2004. ,